Gorilla and King Portfolio Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (2809)	6/20/1999 5:03:00 PM
From: mauser96	Read Replies (1) of 54805

The reason many of us tend to avoid the biotechs is that they are a real crap shoot. The human body is so complex and it's reactions to drugs so unpredictable that even if you have a good background in this field it's hard to be early enough to make money. If something is really good, many of the scientists doing the studies will find a way to break the double blind code and invest before you. A government agency (FDA) can decide something negative and wipe out most of your investment overnight. We like gorillas on this thread because they are the opposite of biotech, they already have a competitive advantage that can be sustained many years. If anybody out there still wants to invest in one, check out Pharmacyclics (PCYC).The science behind this one is very good and innovative, and it's products will (if they work) address a large market. Since phototactivated porphorins somewhat similar to PCYC's products already exist in human disease states, we have some idea of their toxicity in advance. I have a small investment in it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next